Beyond headlines and amyloid, the Alzheimer's pipeline chugs along

We wanted to show the full breadth of the Alzheimer’s pipeline, and, thanks to a new study from the Alzheimer’s Association (AA), we can do just that. Using data scraped from the ClinicalTrials.gov database, AA found that there are currently 143 drugs in the development pipeline for the devastating neurological disorder—not just three—spread across 172 clinical trials.